Weighted co-expression reveals early circadian and metabolic dysregulation in precystic kidneys
- 1Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands
- 2Division of Drug Discovery and Safety, Leiden Academic Center for Drug Research, Leiden, The Netherlands
Abstract
Autosomal dominant polycystic kidney disease (ADPKD) initiates long before cysts appear, yet the molecular triggers of this precystic phase remain poorly defined. To gain more insight into these early alterations, we applied cross-species Weighted Gene Coexpression Network Analysis (WGCNA) to renal transcriptomes from inducible Pkd1-knockout (iKsp-Pkd1del) mice across precystic and cystic stages. Instead of constructing a new network, expression profiles were projected onto three hundred and forty-seven curated rat kidney co-expression modules from the TXG-MAPr framework, enabling direct systems-level comparison with conserved injury signatures. Forty-two transcriptionally active modules emerged, including twenty-one already deregulated during the morphologically normal precystic phase. Early upregulated modules showed activation of circadian regulators (Bmal1/Arntl, Per1, Per3, Npas2) and sterol biosynthesis under Srebf2 control, whereas mitochondrial and oxidative-phosphorylation modules were markedly repressed. Transcription-factor enrichment revealed distinct regulatory axes: circadian control by BMAL1, metabolic regulation through SREBP2 (encoded by Srebf2), and inflammatory/cytokine signaling mediated by STAT3, p53, and NF-κB. These regulatory programs diverged transcriptionally within two weeks of Pkd1 loss, establishing an epithelial-driven phase characterized by circadian misalignment, metabolic rewiring, mitochondrial suppression and concomitant low-level inflammatory signaling. Inflammatory and stress-response modules intensified during later cystic stages. Notably, Pkd2 clustered within a small but transcriptionally active high-ranked module suggesting early perturbation of the polycystin complex. Together, these data define precystic ADPKD as a convergence of independent epithelial programs accompanied by early inflammatory engagement that precedes overt cyst expansion, providing a modular framework for early biomarker discovery and therapeutic targeting.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s00109-026-02731-4.
Related
- Neuro-Metabolic and Vascular Dysregulation are Functional Biomarkers of Acquired Brain Injury
- Experimental and mathematical models reveal that AMPK modulates circadian clock gene expression and period through NAD+-dependent regulation of Bmal1
- Sustained hypoxia induces divergent response patterns in cardiac metabolic-immune adaptation and circadian rhythm regulation
- Metabolic Dysregulation and Metabolite-Targeted Interventions in Autism Spectrum Disorder: Mechanisms and Translational Perspectives
- MicroRNA dysregulation in pemphigus: a systematic review of expression profiles and molecular targets
BibTeX
@article{marino2026weighted,
title = {{Weighted co-expression reveals early circadian and metabolic dysregulation in precystic kidneys}},
author = {Cesare A. Marino and Steven J. Kunnen and Bob van de Water and Dorien J. M. Peters},
journal = {Journal of Molecular Medicine (Berlin, Germany)},
year = {2026},
month = nov,
doi = {10.1007/s00109-026-02731-4},
url = {https://doi.org/10.1007/s00109-026-02731-4},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Weighted co-expression reveals early circadian and metabolic dysregulation in precystic kidneys
AU - Cesare A. Marino
AU - Steven J. Kunnen
AU - Bob van de Water
AU - Dorien J. M. Peters
PY - 2026
DA - 2026/11/03
JO - Journal of Molecular Medicine (Berlin, Germany)
DO - 10.1007/s00109-026-02731-4
UR - https://doi.org/10.1007/s00109-026-02731-4
AB - Autosomal dominant polycystic kidney disease (ADPKD) initiates long before cysts appear, yet the molecular triggers of this precystic phase remain poorly defined. To gain more insight into these early alterations, we applied cross-species Weighted Gene Coexpression Network Analysis (WGCNA) to renal transcriptomes from inducible Pkd1-knockout (iKsp-Pkd1del) mice across precystic and cystic stages. Instead of constructing a new network, expression profiles were projected onto three hundred and forty-seven curated rat kidney co-expression modules from the TXG-MAPr framework, enabling direct systems-level comparison with conserved injury signatures. Forty-two transcriptionally active modules emerged, including twenty-one already deregulated during the morphologically normal precystic phase. Early upregulated modules showed activation of circadian regulators (Bmal1/Arntl, Per1, Per3, Npas2) and sterol biosynthesis under Srebf2 control, whereas mitochondrial and oxidative-phosphorylation modules were markedly repressed. Transcription-factor enrichment revealed distinct regulatory axes: circadian control by BMAL1, metabolic regulation through SREBP2 (encoded by Srebf2), and inflammatory/cytokine signaling mediated by STAT3, p53, and NF-κB. These regulatory programs diverged transcriptionally within two weeks of Pkd1 loss, establishing an epithelial-driven phase characterized by circadian misalignment, metabolic rewiring, mitochondrial suppression and concomitant low-level inflammatory signaling. Inflammatory and stress-response modules intensified during later cystic stages. Notably, Pkd2 clustered within a small but transcriptionally active high-ranked module suggesting early perturbation of the polycystin complex. Together, these data define precystic ADPKD as a convergence of independent epithelial programs accompanied by early inflammatory engagement that precedes overt cyst expansion, providing a modular framework for early biomarker discovery and therapeutic targeting. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s00109-026-02731-4.
SN - 0946-2716
SN - 1432-1440
ER -